Till Holsten
Hamburg, HH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomics.
Journal: Acta neuropathologica
Published: April 21, 2023
ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infant.
Journal: Pediatric blood & cancer
Published: October 20, 2021
Detailed Clinical and Histopathological Description of 8 Cases of Molecularly Defined CNS Neuroblastomas.
Journal: Journal of neuropathology and experimental neurology
Published: December 03, 2020
Single-cell transcriptomics identifies potential cells of origin of MYC rhabdoid tumors.
Journal: Nature communications
Published: October 16, 2020
Ependymoma relapse goes along with a relatively stable epigenome, but a severely altered tumor morphology.
Journal: Brain pathology (Zurich, Switzerland)
Published: April 05, 2020
Pik3ca mutations significantly enhance the growth of SHH medulloblastoma and lead to metastatic tumour growth in a novel mouse model.
Journal: Cancer letters
Published: December 20, 2019
Group 3 medulloblastoma in a patient with a GYS2 germline mutation and glycogen storage disease 0a.
Journal: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
Published: August 18, 2017
Germline variants in SMARCB1 and other members of the BAF chromatin-remodeling complex across human disease entities: a meta-analysis.
Journal: European journal of human genetics : EJHG
Published: May 15, 2017
Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors.
Journal: Oncotarget
Published: January 18, 2017
Liver transplantation as a potentially lifesaving measure in neuroblastoma stage 4S.
Journal: Pediatric hematology and oncology
Published: January 14, 2017
Arsenic trioxide inhibits tumor cell growth in malignant rhabdoid tumors in vitro and in vivo by targeting overexpressed Gli1.
Journal: International journal of cancer
Published: October 22, 2013
Rhabdoid tumors: clinical approaches and molecular targets for innovative therapy.
Journal: Pediatric hematology and oncology
Published: July 16, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026